Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Dermatol Surg ; 44(2): 220-226, 2018 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28858925

RESUMO

BACKGROUND: Post-procedure purpura is a major complaint of patients with port-wine stains (PWSs) treated with pulsed dye laser (PDL). OBJECTIVE: To assess the safety and efficacy of using PDL at nonpurpuric settings to treat ecchymoses that develop within PWSs after treatment with PDL. MATERIALS AND METHODS: Prospective, randomized, controlled study using 595-nm PDL for treatment of PWSs and laser-induced ecchymoses. Port-wine stains were treated in entirety at baseline. Two days later, ecchymoses on randomly selected half of the lesion were re-treated with PDL at subpurpuric settings. Treatment series was repeated 4 to 8 weeks later, and follow-up was at 1 month. Reduction in bruising and PWS clearance were assessed. Three masked evaluators graded clinical improvement using a 4-point scale (1 = 1%-25% improvement, 2 = 26%-50% improvement, 3 = 51%-75% improvement, and 4 = 76%-100% improvement). RESULTS: Twenty adults with 21 PWSs on the head, trunk, and extremities were treated. After first treatment, reduction of bruising was graded a mean value of 2.43 for the treatment side, compared with 1.93 for the control side (p = .012); after the second treatment, 2.83 compared with 2.40 (p = .021). No significant adverse events occurred. CONCLUSION: Pulsed dye laser can be used safely and effectively to reduce treatment-induced purpura in patients with PWSs.


Assuntos
Equimose/etiologia , Equimose/cirurgia , Terapia a Laser , Lasers de Corante/uso terapêutico , Mancha Vinho do Porto/cirurgia , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Projetos Piloto , Estudos Prospectivos , Retratamento , Resultado do Tratamento , Adulto Jovem
2.
Dermatol Online J ; 22(12)2016 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-28329531

RESUMO

Anaplastic large-cell lymphomas (ALCLs) are agroup of CD30-positive non-Hodgkin lymphomasthat are linked by common morphologic andimmunophenotypic features but have varyingclinical and genetic characteristics. The World HealthOrganization classification currently recognizes threesubtypes of ALCL: systemic anaplastic lymphomakinase-positive ALCL, systemic anaplastic lymphomakinase-negative (ALK-) ALCL, and primary cutaneousALCL. Here we present a 42-year-old man with ahistory of systemic ALK- ALCL, who was in remissionfor six months before relapsing with skin-limitedanaplastic large-cell lymphoma.


Assuntos
Linfoma Anaplásico de Células Grandes/diagnóstico , Recidiva Local de Neoplasia/diagnóstico , Neoplasias Cutâneas/diagnóstico , Adulto , Humanos , Linfoma Anaplásico de Células Grandes/patologia , Masculino , Recidiva Local de Neoplasia/patologia , Neoplasias Cutâneas/patologia
3.
J Drugs Dermatol ; 14(9): 1029-34, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26355624

RESUMO

Aesthetics continues to be a rapidly growing field within dermatology. In 2014, Americans spent 5 billion dollars on an estimated 9 million minimally invasive cosmetic procedures. Between 1997 and 2014, the number of aesthetic procedures performed on men increased by 273%. The approach to male aesthetics differs from that of females. Men have a squarer face, a more angled and larger jaw, and equally balanced upper and lower facial proportions. Facial muscle mass, subcutaneous tissue, and blood vessel density are also increased in men relative to women. While many of the same cosmetic procedures are performed in males and females, the approach, assessment, and treatment parameters are often different. Improper technique in a male patient can result in feminizing facial features and patient dissatisfaction. With an increasing number of men seeking aesthetic procedures, it behooves dermatologists to familiarize themselves with male facial anatomy and the practice of cosmetic dermatology in this population.


Assuntos
Dermatologia , Estética , Face/anatomia & histologia , Músculos Faciais/anatomia & histologia , Toxinas Botulínicas Tipo A/uso terapêutico , Técnicas Cosméticas , Preenchedores Dérmicos/uso terapêutico , Humanos , Masculino , Fármacos Neuromusculares/uso terapêutico , Envelhecimento da Pele
4.
Am J Pathol ; 185(3): 704-16, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25579842

RESUMO

The two major melanoma histologic subtypes, superficial spreading and nodular melanomas, differ in their speed of dermal invasion but converge biologically once they invade and metastasize. Herein, we tested the hypothesis that distinct molecular alterations arising in primary melanoma cells might persist as these tumors progress to invasion and metastasis. Ribosomal protein S6 kinase, 90 kDa, polypeptide 1 (RSK1; official name RPS6KA1) was significantly hyperactivated in human melanoma lines and metastatic tissues derived from nodular compared with superficial spreading melanoma. RSK1 was constitutively phosphorylated at Ser-380 in nodular but not superficial spreading melanoma and did not directly correlate with BRAF or MEK activation. Nodular melanoma cells were more sensitive to RSK1 inhibition using siRNA and the pharmacological inhibitor BI-D1870 compared with superficial spreading cells. Gene expression microarray analyses revealed that RSK1 orchestrated a program of gene expression that promoted cell motility and invasion. Differential overexpression of the prometastatic matrix metalloproteinase 8 and tissue inhibitor of metalloproteinases 1 in metastatic nodular compared with metastatic superficial spreading melanoma was observed. Finally, using an in vivo zebrafish model, constitutive RSK1 activation increased melanoma invasion. Together, these data reveal a novel role for activated RSK1 in the progression of nodular melanoma and suggest that melanoma originating from different histologic subtypes may be biologically distinct and that these differences are maintained as the tumors invade and metastasize.


Assuntos
Movimento Celular , Melanoma/metabolismo , Invasividade Neoplásica/patologia , Proteínas Quinases S6 Ribossômicas 90-kDa/metabolismo , Neoplasias Cutâneas/metabolismo , Animais , Linhagem Celular Tumoral , Progressão da Doença , Humanos , Melanoma/patologia , Fosforilação , Neoplasias Cutâneas/patologia , Peixe-Zebra
5.
Dermatol Online J ; 21(12)2015 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-26990330

RESUMO

Angiolymphoid hyperplasia with eosinophilia is a rare, benign, vascular proliferation that presents as dome-shaped, light-pink-to-red-brown papules or subcutaneous masses that lack distinguishing surface changes. The condition typically presents as a single lesion or multiple lesions that involve contiguous areas. The pathogenesis is poorly understood. Angiolymhpoid hyperplasia with eosinophilia has been associated with antecedent trauma, T-cell proliferation, infection, and hormone imbalance. This report details a case of widespread angiolymphoid hyperplasia with eosinophilia that flared while the patient was pregnant.


Assuntos
Hiperplasia Angiolinfoide com Eosinofilia/diagnóstico , Complicações na Gravidez , Pele/patologia , Abdome , Adulto , Braço , Biópsia , Feminino , Humanos , Perna (Membro) , Pescoço , Gravidez , Tórax
6.
Dermatol Online J ; 21(12)2015 Dec 16.
Artigo em Inglês | MEDLINE | ID: mdl-26990342

RESUMO

We report the first case of direct immunoflourescence-proven immunoglobulin A (IgA) vasculitis associated with influenza infection in an adult patient. IgA vasculitis, which was previously known as Henoch-Schönlein purpura, is the most common systemic vasculitis in children but rarely occurs in adults. Disease onset often occurs after upper respiratory tract infections that are caused by adenovirus or enterovirus. The American College of Rheumatology defines IgA vasculitis by the presence of any two of the following four criteria: age ≤ 20 years at disease onset, palpable purpura, acute abdominal pain, and a biopsy specimen that shows granulocytes in the walls of small arterioles or venules. Purpura, abdominal pain, and arthralgia comprise the classic triad. Renal involvement may be severe, especially in adults. Treatment is most often supportive but glucocorticoids and/or immunosuppressive agents are recommended in severe or refractory cases.


Assuntos
Anticorpos Anti-Idiotípicos/imunologia , Vasculite por IgA/diagnóstico , Imunoglobulina A/imunologia , Pele/patologia , Adulto , Biópsia , Feminino , Humanos , Vasculite por IgA/imunologia , Pele/irrigação sanguínea
8.
Sports Med ; 43(7): 575-89, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23456491

RESUMO

Each year in the United States over 80 million people participate in bat-and-ball sports, for example baseball and softball. Cricket, the world's second most popular sport, is enjoyed by hundreds of millions of participants in such countries as India, Pakistan, Australia, New Zealand, Bangladesh, South Africa, West Indies, Sri Lanka, United Kingdom, and Zimbabwe. Although any player can develop skin disease as a result of participation in these bat-and-ball sports, competitive team athletes are especially prone to skin problems related to infection, trauma, allergy, solar exposure, and other causes. These diseases can produce symptoms that hinder individual athletic performance and participation. In this review, we discuss the diagnosis and best-practice management of skin diseases that can develop as a result of participation in baseball, softball, and cricket.


Assuntos
Beisebol , Dermatopatias/etiologia , Anabolizantes/efeitos adversos , Androgênios/efeitos adversos , Beisebol/lesões , Contusões/diagnóstico , Contusões/etiologia , Contusões/terapia , Dermatite de Contato/diagnóstico , Dermatite de Contato/etiologia , Dermatite de Contato/terapia , Toxidermias/diagnóstico , Toxidermias/etiologia , Toxidermias/terapia , Humanos , Púrpura/diagnóstico , Púrpura/etiologia , Púrpura/terapia , Dermatopatias/diagnóstico , Dermatopatias/terapia , Dermatopatias Infecciosas/diagnóstico , Dermatopatias Infecciosas/etiologia , Dermatopatias Infecciosas/terapia , Esteroides/efeitos adversos , Queimadura Solar/diagnóstico , Queimadura Solar/etiologia , Queimadura Solar/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA